Pfizer’s Breast Cancer Treatment Fails in an Advanced Trial. The Stock Is Falling. – Barron's
Business News
- Pfizer’s Breast Cancer Treatment Fails in an Advanced Trial. The Stock Is Falling. Barron’s
- Why Pfizer’s Shares Are Slipping 7.6% Today Motley Fool
- PFE Stock Dives After Breast Cancer Drug Misses Its Mark Investor’s Business Daily
- Pfizer’s stock tumbles to pace the Dow’s decliners, would cut about 17 points off the Dow’s price MarketWatch
- Pfizer declines about 8% after setback to breast cancer treatment Yahoo Finance
- View Full Coverage on Google News
Source: Business News